Genprex (GNPX) Projected to Announce Earnings on Monday

Genprex (NASDAQ:GNPX) will likely be posting its quarterly earnings results before the market opens on Monday, April 7th. Analysts expect Genprex to post earnings of ($0.39) per share for the quarter.

Genprex Stock Performance

Shares of GNPX stock opened at $0.27 on Monday. Genprex has a 12-month low of $0.25 and a 12-month high of $4.09. The firm’s 50 day moving average is $0.45 and its 200 day moving average is $0.82.

Genprex Company Profile

Genprex, Inc, a clinical-stage gene therapy company, focuses on developing gene-based therapies for patients with cancer and diabetes in the United States. The company's lead product candidate is REQORSA (GPX-001), which is in preclinical trials to treat non-small cell lung cancer and small cell lung cancer; and GPX-002, which is in preclinical trials to treat type 1 and type 2 diabetes.